Indivior Pharmaceuticals, Inc. (SPUN)
NASDAQ: SPUN · Real-Time Price · USD
36.28
+0.91 (2.57%)
At close: Nov 2, 2026
Indivior Pharmaceuticals Employees
As of December 31, 2025, Indivior Pharmaceuticals had 838 total employees, including 827 full-time and 11 part-time employees. The number of employees decreased by 213 or 20.27% compared to the previous year.
Employees
838
Change (1Y)
-213
Growth (1Y)
-20.27%
Revenue / Employee
$1,639,618
Profits / Employee
$536,993
Market Cap
4.28B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 838 | -213 | -20.27% | 827 | 11 |
| Dec 31, 2024 | 1,051 | -113 | -9.71% | 1,030 | 21 |
| Dec 31, 2023 | 1,164 | 236 | 25.43% | 1,164 | 0 |
| Dec 31, 2022 | 928 | 43 | 4.86% | 928 | 0 |
| Dec 31, 2021 | 885 | 97 | 12.31% | 885 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
SPUN News
- 5 days ago - Indivior Pharmaceuticals Earnings release: Q3 2026 - Filings
- 5 days ago - Indivior Pharmaceuticals Quarterly report: Q3 2026 - Filings
- 5 days ago - Indivior Reports Third Quarter 2026 Financial Results - GlobeNewsWire
- 15 days ago - Indivior to Report Third Quarter 2026 Financial Results - GlobeNewsWire
- 19 days ago - Indivior Pharmaceuticals Transcript: EGM 2026 - Transcripts
- 6 weeks ago - Indivior Pharmaceuticals, Inc. Declares Special Cash Dividend - GlobeNewsWire
- 3 months ago - Indivior Pharmaceuticals Slides: Corporate presentation - Filings
- 3 months ago - Indivior Pharmaceuticals Earnings Call Transcript: Q2 2026 - Transcripts